ArticleRMD open2025

Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 study.

María Ángeles Puche-Larrubia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.